Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3
Price to sales ratio
0.05

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4082
CSBR
Champions Oncology, Inc. - Common Stock
5.78 USD-0.52%-2.86%-10.94%-28.20%80.27 M USD
4099
HRTX
Heron Therapeutics, Inc. - Common Stock
0.42 USD0.00%0.00%0.00%-80.19%79.50 M USD
4104
ENTX
Entera Bio Ltd. - Ordinary Shares
1.66 USD+1.22%-1.19%+32.80%-6.21%81.71 M USD
4116
GANX
Gain Therapeutics, Inc. - Common Stock
1.82 USD+3.41%-0.55%+6.43%-2.15%77.63 M USD

Frequently asked questions about Rani Therapeutics Holdings, Inc. - Class A Common Stock

What is the Rani Therapeutics Holdings, Inc. - Class A Common Stock stock price today?

The current price of Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI) is 0.66. Over the past 24 hours, the stock has changed by +4.76%. Follow the RANI chart for real-time price dynamics.

What is the stock ticker of Rani Therapeutics Holdings, Inc. - Class A Common Stock?

Rani Therapeutics Holdings, Inc. - Class A Common Stock trades under the ticker RANI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Rani Therapeutics Holdings, Inc. - Class A Common Stock stock going up?

RANI has changed by -15.38% over the last week, -17.50% over the last month, and +34.69% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Rani Therapeutics Holdings, Inc. - Class A Common Stock net income for the last quarter?

Rani Therapeutics Holdings, Inc. - Class A Common Stock reported net income of -7.03 M for the last quarter. The previous quarter showed -10.3 M, which means net income changed by +31.75%.

How many employees does Rani Therapeutics Holdings, Inc. - Class A Common Stock have?

As of the latest available data, Rani Therapeutics Holdings, Inc. - Class A Common Stock has 69 employees. Workforce size can provide additional context about the company's scale and operations.

What is Rani Therapeutics Holdings, Inc. - Class A Common Stock EBITDA?

Rani Therapeutics Holdings, Inc. - Class A Common Stock EBITDA is -8.38 M, and its EBITDA margin is -490.81%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Rani Therapeutics Holdings, Inc. - Class A Common Stock stock?

You can buy Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Rani Therapeutics Holdings, Inc. - Class A Common Stock stock?

Investing in Rani Therapeutics Holdings, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RANI chart and related analysis on metatrader.com as part of your research.

News